{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["MAPK signalling pathways", "RPMTG", "apoptosis", "cell cycle arrest", "colorectal cancer"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34080021", "DateCompleted": {"Year": "2021", "Month": "10", "Day": "22"}, "DateRevised": {"Year": "2021", "Month": "10", "Day": "22"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "06", "Day": "03"}], "Language": ["eng"], "ELocationID": ["542", "10.3892/mmr.2021.12181"], "Journal": {"ISSN": "1791-3004", "JournalIssue": {"Volume": "24", "Issue": "2", "PubDate": {"Year": "2021", "Month": "Aug"}}, "Title": "Molecular medicine reports", "ISOAbbreviation": "Mol Med Rep"}, "ArticleTitle": "Total saponins from Rhizoma Panacis Majoris inhibit proliferation, induce cell cycle arrest and apoptosis and influence MAPK signalling pathways on the colorectal cancer cell.", "Abstract": {"AbstractText": ["Colorectal cancer (CRC) ranks third in incidence and second in mortality among all types of cancer, and due to its insidious onset and lack of early symptoms, it is usually diagnosed at a later stage. Saponins, a class of compounds abundant in plants, have been reported to possess prominent anti\u2011tumour properties. The use of ginsenoside Rg3 in the clinical setting was authorized by the National Medicinal Products Administration of China. In the present study, total saponins from Rhizoma Panacis Majoris\u00a0(RPMTG) were prepared, and the pharmacological mechanisms underlying the anti\u2011CRC effects of RPMTG were investigated. The effect of RPMTG on the proliferation, cell cycle progression and apoptosis of HCT116 and SW620 cells were detected by MTT, flow cytometry and western blotting assays, and it was demonstrated that RPMTG could inhibit the proliferation of HCT116 and SW620 cells with IC50 values of 315.8 and 355.1\u00a0<i>\u00b5</i>g/ml, respectively, induce cell cycle arrest in the S and G0/G1\u00a0phase, and trigger apoptosis by downregulating the expression of the anti\u2011apoptotic proteins Bcl\u20112, Bcl\u2011xL and induced myeloid leukaemia cell differentiation protein Mcl\u20111, and increasing the expression of the pro\u2011apoptotic proteins Bax and Bad, cleaved caspased\u20113 and poly(ADP)\u2011ribose polymerase. These findings suggested that RPMTG induced apoptosis through mitochondrial\u2011related pathways. In addition, RPMTG also decreased the expression of phosphorylated (p)\u2011extracellular signal\u2011regulated kinase and increased p\u2011c\u2011Jun N\u2011terminal kinase\u00a0(p\u2011JNK) and p\u2011p38. Moreover, the effects of RPMTG on cell proliferation and apoptosis were partially reversed when the JNK and p38 mitogen\u2011activated protein kinase (MAPK) pathways were inhibited, indicating that RPMTG triggered apoptosis mainly via regulating JNK and p38 MAPK signalling. Therefore, RPMTG may have potential as an anti\u2011CRC agent, and further evaluations are needed."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Research and Development of Characteristic Qin Medicine Resources (Cultivation)/Co-construction Collaborative Innovation Center for Chinese Medicine Resources Industrialization by Shaanxi and Education Ministry/Shaanxi Innovative Drug Research Center, School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi 712046, P.R. China."}], "LastName": "Chang", "ForeName": "Lu", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Research and Development of Characteristic Qin Medicine Resources (Cultivation)/Co-construction Collaborative Innovation Center for Chinese Medicine Resources Industrialization by Shaanxi and Education Ministry/Shaanxi Innovative Drug Research Center, School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi 712046, P.R. China."}], "LastName": "Zhou", "ForeName": "Rui", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Research and Development of Characteristic Qin Medicine Resources (Cultivation)/Co-construction Collaborative Innovation Center for Chinese Medicine Resources Industrialization by Shaanxi and Education Ministry/Shaanxi Innovative Drug Research Center, School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi 712046, P.R. China."}], "LastName": "He", "ForeName": "Yihan", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Research and Development of Characteristic Qin Medicine Resources (Cultivation)/Co-construction Collaborative Innovation Center for Chinese Medicine Resources Industrialization by Shaanxi and Education Ministry/Shaanxi Innovative Drug Research Center, School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi 712046, P.R. China."}], "LastName": "Meng", "ForeName": "Mei", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Research and Development of Characteristic Qin Medicine Resources (Cultivation)/Co-construction Collaborative Innovation Center for Chinese Medicine Resources Industrialization by Shaanxi and Education Ministry/Shaanxi Innovative Drug Research Center, School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi 712046, P.R. China."}], "LastName": "Hu", "ForeName": "Jinhang", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Research and Development of Characteristic Qin Medicine Resources (Cultivation)/Co-construction Collaborative Innovation Center for Chinese Medicine Resources Industrialization by Shaanxi and Education Ministry/Shaanxi Innovative Drug Research Center, School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi 712046, P.R. China."}], "LastName": "Liu", "ForeName": "Yanru", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Research and Development of Characteristic Qin Medicine Resources (Cultivation)/Co-construction Collaborative Innovation Center for Chinese Medicine Resources Industrialization by Shaanxi and Education Ministry/Shaanxi Innovative Drug Research Center, School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi 712046, P.R. China."}], "LastName": "Pan", "ForeName": "Yalei", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Research and Development of Characteristic Qin Medicine Resources (Cultivation)/Co-construction Collaborative Innovation Center for Chinese Medicine Resources Industrialization by Shaanxi and Education Ministry/Shaanxi Innovative Drug Research Center, School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi 712046, P.R. China."}], "LastName": "Tang", "ForeName": "Zhishu", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Research and Development of Characteristic Qin Medicine Resources (Cultivation)/Co-construction Collaborative Innovation Center for Chinese Medicine Resources Industrialization by Shaanxi and Education Ministry/Shaanxi Innovative Drug Research Center, School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi 712046, P.R. China."}], "LastName": "Yue", "ForeName": "Zhenggang", "Initials": "Z"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Greece", "MedlineTA": "Mol Med Rep", "NlmUniqueID": "101475259", "ISSNLinking": "1791-2997"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}, {"RegistryNumber": "0", "NameOfSubstance": "Mitochondrial Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Protein Kinase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Saponins"}, {"RegistryNumber": "EC 2.7.11.24", "NameOfSubstance": "JNK Mitogen-Activated Protein Kinases"}, {"RegistryNumber": "EC 2.7.11.24", "NameOfSubstance": "p38 Mitogen-Activated Protein Kinases"}], "MeshHeadingList": [{"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Cycle Checkpoints"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": ["drug therapy", "pathology"], "DescriptorName": "Colorectal Neoplasms"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "JNK Mitogen-Activated Protein Kinases"}, {"QualifierName": ["drug effects"], "DescriptorName": "MAP Kinase Signaling System"}, {"QualifierName": ["drug effects"], "DescriptorName": "Mitochondrial Proteins"}, {"QualifierName": ["chemistry"], "DescriptorName": "Panax"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Protein Kinase Inhibitors"}, {"QualifierName": ["chemistry"], "DescriptorName": "Rhizome"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Saponins"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "p38 Mitogen-Activated Protein Kinases"}], "CoiStatement": "The authors declare that they have no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424. doi: 10.3322/caac.21492.", "ArticleIdList": ["10.3322/caac.21492", "30207593"]}, {"Citation": "Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66:683\u2013691. doi: 10.1136/gutjnl-2015-310912.", "ArticleIdList": ["10.1136/gutjnl-2015-310912", "26818619"]}, {"Citation": "Ma M, Wang X, Liu N, Shan F, Feng Y. Low-dose naltrexone inhibits colorectal cancer progression and promotes apoptosis by increasing M1-type macrophages and activating the Bax/Bcl-2/caspase-3/PARP pathway. Int Immunopharmacol. 2020;83:106388. doi: 10.1016/j.intimp.2020.106388.", "ArticleIdList": ["10.1016/j.intimp.2020.106388", "32171145"]}, {"Citation": "Sun J, Feng Y, Wang Y, Ji Q, Cai G, Shi L, Wang Y, Huang Y, Zhang J, Li Q. \u03b1-hederin induces autophagic cell death in colorectal cancer cells through reactive oxygen species dependent AMPK/mTOR signaling pathway activation. Int J Oncol. 2019;54:1601\u20131612.", "ArticleIdList": ["PMC6438428", "30896843"]}, {"Citation": "Liu Z, Xiong L, Ouyang G, Ma L, Sahi S, Wang K, Lin L, Huang H, Miao X, Chen W, et al. Investigation of copper cysteamine nanoparticles as a new type of radiosensitiers for colorectal carcinoma Treatment. Sci Rep. 2017;7:9290. doi: 10.1038/s41598-017-09375-y.", "ArticleIdList": ["10.1038/s41598-017-09375-y", "PMC5570927", "28839163"]}, {"Citation": "Hu M, Yu Z, Mei P, Li J, Luo D, Zhang H, Zhou M, Liang F, Chen R. Correction for: Lycorine induces autophagy-associated apoptosis by targeting MEK2 and enhances vemurafenib activity in colorectal cancer. Aging (Albany NY) 2020;12:6488\u20136489. doi: 10.18632/aging.103011.", "ArticleIdList": ["10.18632/aging.103011", "PMC7185100", "32244227"]}, {"Citation": "Weaver BA. How Taxol/paclitaxel kills cancer cells. Mol Biol Cell. 2014;25:2677\u20132681. doi: 10.1091/mbc.e14-04-0916.", "ArticleIdList": ["10.1091/mbc.e14-04-0916", "PMC4161504", "25213191"]}, {"Citation": "GLB: L. Gatti. Perego P, Zaffaroni N. Camptothecin resistance in cancer: Insights into the molecular mecha-nisms of a DNA-damaging drug. Curr Med Chem. 2013;20:1541\u20131565. doi: 10.2174/0929867311320120006.", "ArticleIdList": ["10.2174/0929867311320120006", "23432590"]}, {"Citation": "Paidakula S, Nerella S, Vadde R, Kamal A, Kankala S. Design and synthesis of 4\u03b2-acetamidobenzofuranone-podophyllotoxin hybrids and their anti-cancer evaluation. Bioorg Med Chem Lett. 2019;29:2153\u20132156. doi: 10.1016/j.bmcl.2019.06.060.", "ArticleIdList": ["10.1016/j.bmcl.2019.06.060", "31281022"]}, {"Citation": "Man S, Gao W, Zhang Y, Huang L, Liu C. Chemical study and medical application of saponins as anti-cancer agents. Fitoterapia. 2010;81:703\u2013714. doi: 10.1016/j.fitote.2010.06.004.", "ArticleIdList": ["10.1016/j.fitote.2010.06.004", "20550961"]}, {"Citation": "Choi JS, Chun KS, Kundu J, Kundu JK. Biochemical basis of cancer chemoprevention and/or chemotherapy with ginsenosides (Review) Int J Mol Med. 2013;32:1227\u20131238. doi: 10.3892/ijmm.2013.1519.", "ArticleIdList": ["10.3892/ijmm.2013.1519", "24126942"]}, {"Citation": "Lee DG, Jang SI, Kim YR, Yang KE, Yoon SJ, Lee ZW, An HJ, Jang IS, Choi JS, Yoo HS. Anti-proliferative effects of ginsenosides extracted from mountain ginseng on lung cancer. Chin J Integr Med. 2016;22:344\u2013352. doi: 10.1007/s11655-014-1789-8.", "ArticleIdList": ["10.1007/s11655-014-1789-8", "25159864"]}, {"Citation": "Sun M, Ye Y, Xiao L, Duan X, Zhang Y, Zhang H. Anticancer effects of ginsenoside Rg3 (Review) Int J Mol Med. 2017;39:507\u2013518. doi: 10.3892/ijmm.2017.2857.", "ArticleIdList": ["10.3892/ijmm.2017.2857", "28098857"]}, {"Citation": "Song X, Wang W, Zhang X, Jiang Y, Yang X, Deng C, Yue Z, Tang Z. Deglucose chikusetsusaponin IVa isolated from Rhizoma Panacis Majoris induces apoptosis in human HepG2 hepatoma cells. Mol Med Rep. 2015;12:5494\u20135500. doi: 10.3892/mmr.2015.4035.", "ArticleIdList": ["10.3892/mmr.2015.4035", "26151883"]}, {"Citation": "Chen T, Chen LF, Jin GQ, Li D. Panax japlcus var induced apoptosis of human hepatocarcinoma cells in vitro. Tumor. 2006;26:144\u2013147. (In Chinese)", "ArticleIdList": ["0"]}, {"Citation": "Chen T, Chen M, Hu Y, Gong Z, Deng L. Extraction and anticancer activity of polysaccharide from Rhizoma Panacis Majoris. Chinese Journal of Traditional Chinese Medicine. 2010;35:912\u2013914. (In Chinese)"}, {"Citation": "Sun Y, Liu WZ, Liu T, Feng X, Yang N, Zhou HF. Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. J Recept Signal Transduct Res. 2015;35:600\u2013604. doi: 10.3109/10799893.2015.1030412.", "ArticleIdList": ["10.3109/10799893.2015.1030412", "26096166"]}, {"Citation": "Wagner EF, Nebreda \u00c1R. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer. 2009;9:537\u2013549. doi: 10.1038/nrc2694.", "ArticleIdList": ["10.1038/nrc2694", "19629069"]}, {"Citation": "Pag\u00e8s PB, Le Pimpec-Barthes F, Bernard A. Surgery for pulmonary metastases from colorectal cancer: Predictive factors for survival. Rev Mal Respir. 2016;33:838\u2013852. doi: 10.1016/j.rmr.2016.02.006. (In French)", "ArticleIdList": ["10.1016/j.rmr.2016.02.006", "27133381"]}, {"Citation": "Zhao M, Chen Q, Xu W, Wang H, Che Y, Wu M, Wang L, Lijuan C, Hao H. Total ginsenosides extract induce autophagic cell death in NSCLC cells through activation of endoplasmic reticulum stress. J Ethnopharmacol. 2019;243:112093. doi: 10.1016/j.jep.2019.112093.", "ArticleIdList": ["10.1016/j.jep.2019.112093", "31325602"]}, {"Citation": "Huang Y, Huang H, Han Z, Li W, Mai Z, Yuan R. Ginsenoside Rh2 inhibits angiogenesis in prostate cancer by targeting CNNM1. J Nanosci Nanotechnol. 2019;19:1942\u20131950. doi: 10.1166/jnn.2019.16404.", "ArticleIdList": ["10.1166/jnn.2019.16404", "30486934"]}, {"Citation": "Jeong D, Ham J, Park S, Kim HW, Kim H, Ji HW, Kim SJ. Ginsenoside Rh2 suppresses breast cancer cell proliferation by epigenetically regulating the long noncoding RNA C3orf67-AS1. Am J Chin Med. 2019;47:1643\u20131658. doi: 10.1142/S0192415X19500848.", "ArticleIdList": ["10.1142/S0192415X19500848", "31645124"]}, {"Citation": "Tang YC, Zhang Y, Zhou J, Zhi Q, Wu MY, Gong FR, Shen M, Liu L, Tao M, Shen B, et al. Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo. Int J Oncol. 2018;52:127\u2013138.", "ArticleIdList": ["PMC5743384", "29115601"]}, {"Citation": "Nakhjavani M, Hardingham JE, Palethorpe HM, Tomita Y, Smith E, Price TJ, Townsend AR. Ginsenoside Rg3: Potential Molecular Targets and Therapeutic Indication in Metastatic Breast Cancer. Medicines (Basel) 6(17):62019.", "ArticleIdList": ["PMC6473622", "30678106"]}, {"Citation": "Kim DG, Jung KH, Lee DG, Yoon JH, Choi KS, Kwon SW, Shen HM, Morgan MJ, Hong SS, Kim YS. 20(S)-Ginsenoside Rg3 is a novel inhibitor of autophagy and sensitizes hepatocellular carcinoma to doxorubicin. Oncotarget. 2014;5:4438\u20134451. doi: 10.18632/oncotarget.2034.", "ArticleIdList": ["10.18632/oncotarget.2034", "PMC4147336", "24970805"]}, {"Citation": "Zhang Q, Kang X, Zhao W. Antiangiogenic effect of low-dose cyclophosphamide combined with ginsenoside Rg3 on Lewis lung carcinoma. Biochem Biophys Res Commun. 2006;342:824\u2013828. doi: 10.1016/j.bbrc.2006.02.044.", "ArticleIdList": ["10.1016/j.bbrc.2006.02.044", "16499874"]}, {"Citation": "Coffman JA. Cell cycle development. Dev Cell. 2004;6:321\u2013327. doi: 10.1016/S1534-5807(04)00067-X.", "ArticleIdList": ["10.1016/S1534-5807(04)00067-X", "15030756"]}, {"Citation": "Park M-T, Lee S-J. Cell cycle and cancer. J Biochem Mol Biol. 2003;36:60\u201365.", "ArticleIdList": ["12542976"]}, {"Citation": "Schafer KA. The cell cycle: A review. Vet Pathol. 1998;35:461\u2013478. doi: 10.1177/030098589803500601.", "ArticleIdList": ["10.1177/030098589803500601", "9823588"]}, {"Citation": "Kaczanowski S. Apoptosis: its origin, history, maintenance and the medical implications for cancer and aging. Phys Biol. 2016;13:3. doi: 10.1088/1478-3975/13/3/031001.", "ArticleIdList": ["10.1088/1478-3975/13/3/031001", "27172135"]}, {"Citation": "Wong RS. Apoptosis in cancer: From pathogenesis to treatment. J Exp Clin Cancer Res. 2011;30:87. doi: 10.1186/1756-9966-30-87.", "ArticleIdList": ["10.1186/1756-9966-30-87", "PMC3197541", "21943236"]}, {"Citation": "Arumugam A, Razis AF. Apoptosis as a mechanism of the cancer chemopreventive activity of glucosinolates: A Review. Asian Pac J Cancer Prev. 2018;19:1439\u20131448.", "ArticleIdList": ["PMC6103590", "29936713"]}, {"Citation": "Pistritto G, Trisciuoglio D, Ceci C, Garufi A, D'Orazi G. Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies. Aging (Albany NY) 2016;8:603\u2013619. doi: 10.18632/aging.100934.", "ArticleIdList": ["10.18632/aging.100934", "PMC4925817", "27019364"]}, {"Citation": "Liu T, Wu Z, He Y, Xiao Y, Xia C. Single and dual target inhibitors based on Bcl-2: Promising anti-tumor agents for cancer therapy. Eur J Med Chem. 2020;201:112446. doi: 10.1016/j.ejmech.2020.112446.", "ArticleIdList": ["10.1016/j.ejmech.2020.112446", "32563811"]}, {"Citation": "Kalpage HA, Wan J, Morse PT, Zurek MP, Turner AA, Khobeir A, Yazdi N, Hakim L, Liu J, Vaishnav A, et al. Cytochrome c phosphorylation: Control of mitochondrial electron transport chain flux and apoptosis. Int J Biochem Cell Biol. 2020;121:105704. doi: 10.1016/j.biocel.2020.105704.", "ArticleIdList": ["10.1016/j.biocel.2020.105704", "PMC7044036", "32023432"]}, {"Citation": "Sun J, Nan G. The mitogen-activated protein kinase (MAPK) signaling pathway as a discovery target in stroke. J Mol Neurosci. 2016;59:90\u201398. doi: 10.1007/s12031-016-0717-8.", "ArticleIdList": ["10.1007/s12031-016-0717-8", "26842916"]}, {"Citation": "Raman M, Chen W, Cobb MH. Differential regulation and properties of MAPKs. Oncogene. 2007;26:3100\u20133112. doi: 10.1038/sj.onc.1210392.", "ArticleIdList": ["10.1038/sj.onc.1210392", "17496909"]}, {"Citation": "Fang JY, Richardson BC. The MAPK signalling pathways and colorectal cancer. Lancet Oncol. 2005;6:322\u2013327. doi: 10.1016/S1470-2045(05)70168-6.", "ArticleIdList": ["10.1016/S1470-2045(05)70168-6", "15863380"]}, {"Citation": "Berlowska J, Dudkiewicz M, Kregiel D, Czyzowska A, Witonska I. Cell lysis induced by membrane-damaging detergent saponins from Quillaja saponaria. Enzyme Microb Technol. 2015;75-76:44\u201348. doi: 10.1016/j.enzmictec.2015.04.007.", "ArticleIdList": ["10.1016/j.enzmictec.2015.04.007", "26047915"]}, {"Citation": "Rao AV, Sung MK. Saponins as anticarcinogens. J Nutr. 1995;125(Suppl 3):717S\u2013724S.", "ArticleIdList": ["7884557"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "11", "Day": "20"}, {"Year": "2021", "Month": "4", "Day": "20"}, {"Year": "2021", "Month": "6", "Day": "3", "Hour": "6", "Minute": "48"}, {"Year": "2021", "Month": "6", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "2", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "5", "Day": "29"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34080021", "PMC8185512", "10.3892/mmr.2021.12181", "542"]}}], "PubmedBookArticle": []}